© 2021 MJH Life Sciences and Consultant Live. All rights reserved.
August 12, 2021
The combination agent breaks ground as the first treatment approved for this indication.
July 06, 2021
Patients included in the high-dose group demonstrated statistically significant improvements compared to placebo for MDS-UPDRS total score.
April 17, 2021
The investigators generated a list of 250 genes that are known to regulate individual reactions within the component pathways of the Alzheimer Disease Aberrant Metabolism (ADAM) network.
April 02, 2021
If approved, daridorexant would become the first sleep medication to demonstrate an improvement in sleep and daytime functioning.